State of Alaska Department of Revenue raised its position in Agilent Technologies Inc (NYSE:A) by 190.2% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 57,154 shares of the medical research company’s stock after acquiring an additional 37,460 shares during the quarter. State of Alaska Department of Revenue’s holdings in Agilent Technologies were worth $3,826,000 at the end of the most recent quarter.
A number of other hedge funds have also recently bought and sold shares of the business. TimesSquare Capital Management LLC purchased a new position in Agilent Technologies during the 3rd quarter valued at approximately $58,550,000. Voya Investment Management LLC grew its holdings in Agilent Technologies by 444.0% during the 2nd quarter. Voya Investment Management LLC now owns 1,032,128 shares of the medical research company’s stock valued at $61,215,000 after buying an additional 842,398 shares in the last quarter. Janus Henderson Group PLC grew its holdings in Agilent Technologies by 2,135.0% during the 2nd quarter. Janus Henderson Group PLC now owns 836,051 shares of the medical research company’s stock valued at $49,587,000 after buying an additional 798,643 shares in the last quarter. Vanguard Group Inc. grew its holdings in Agilent Technologies by 3.0% during the 2nd quarter. Vanguard Group Inc. now owns 22,093,669 shares of the medical research company’s stock valued at $1,310,374,000 after buying an additional 637,698 shares in the last quarter. Finally, Bank of Montreal Can grew its holdings in Agilent Technologies by 187.3% during the 4th quarter. Bank of Montreal Can now owns 742,001 shares of the medical research company’s stock valued at $49,693,000 after buying an additional 483,721 shares in the last quarter.
Shares of Agilent Technologies Inc (A) traded up $1.36 during mid-day trading on Wednesday, hitting $69.70. The stock had a trading volume of 3,637,470 shares, compared to its average volume of 2,210,000. The firm has a market cap of $22,510.00, a PE ratio of 33.35, a PEG ratio of 2.07 and a beta of 1.28. The company has a current ratio of 3.30, a quick ratio of 2.85 and a debt-to-equity ratio of 0.37. Agilent Technologies Inc has a fifty-two week low of $50.09 and a fifty-two week high of $75.00.
Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Monday, November 20th. The medical research company reported $0.67 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.62 by $0.05. The business had revenue of $1.19 billion during the quarter, compared to analysts’ expectations of $1.17 billion. Agilent Technologies had a return on equity of 16.95% and a net margin of 15.30%. The company’s revenue for the quarter was up 7.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.59 EPS. research analysts expect that Agilent Technologies Inc will post 2.58 EPS for the current year.
A number of brokerages recently issued reports on A. Cowen reissued a “hold” rating and set a $70.00 price target on shares of Agilent Technologies in a research note on Wednesday, November 22nd. Evercore ISI assumed coverage on Agilent Technologies in a research note on Wednesday, January 3rd. They set an “outperform” rating and a $75.00 price target for the company. Robert W. Baird reaffirmed a “buy” rating and set a $72.00 target price on shares of Agilent Technologies in a research report on Friday, November 24th. Zacks Investment Research raised Agilent Technologies from a “hold” rating to a “buy” rating and set a $76.00 target price for the company in a research report on Tuesday, October 31st. Finally, JPMorgan Chase & Co. lifted their target price on Agilent Technologies to $75.00 and gave the company an “overweight” rating in a research report on Tuesday, November 21st. Six analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. Agilent Technologies has an average rating of “Buy” and an average target price of $69.25.
In other Agilent Technologies news, CFO Didier Hirsch sold 12,964 shares of the business’s stock in a transaction that occurred on Wednesday, November 22nd. The stock was sold at an average price of $69.00, for a total transaction of $894,516.00. Following the completion of the sale, the chief financial officer now directly owns 184,851 shares in the company, valued at approximately $12,754,719. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, CEO Michael R. Mcmullen sold 22,481 shares of the business’s stock in a transaction that occurred on Monday, November 20th. The stock was sold at an average price of $70.00, for a total value of $1,573,670.00. Following the sale, the chief executive officer now owns 327,882 shares of the company’s stock, valued at $22,951,740. The disclosure for this sale can be found here. In the last three months, insiders sold 219,991 shares of company stock valued at $15,468,795.
COPYRIGHT VIOLATION NOTICE: This piece of content was originally published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this piece of content on another domain, it was copied illegally and republished in violation of United States and international trademark and copyright legislation. The legal version of this piece of content can be accessed at https://www.dispatchtribunal.com/2018/02/14/agilent-technologies-inc-a-holdings-lifted-by-state-of-alaska-department-of-revenue.html.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.